2021
DOI: 10.3390/nu13082531
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Soy Protein Containing of Isoflavones and Isoflavones Extract on Plasma Lipid Profile in Postmenopausal Women as a Potential Prevention Factor in Cardiovascular Diseases: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Abstract: The aim of the report was to evaluate the impact of soy protein containing isoflavones and soy isoflavones extract on lipid profile in postmenopausal women, as compared with placebo or protein of milk, casein or isolated soy protein with or without trace isoflavone content. We used the following databases: MEDLINE (PubMed), EMBASE and the Cochrane Library. Quantitative data synthesis was performed by applying a random-effects model. Subgroup analysis and meta-regression were performed to assess the modifiers o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 69 publications
(336 reference statements)
0
11
0
Order By: Relevance
“…For RCTs using soy protein as plant protein source, we included only RCTs intervening soy with zero or low isoflavone content and excluded those with moderate or high isoflavone content. For interventions using soy protein with different levels of isoflavones, only the group with the lowest isoflavone content was included to discount effects of isoflavones and focus on those of the protein ( 16 ). Outcomes included CVD (mortality and incidence), T2D, and related cardiometabolic risk factors.…”
Section: Methodsmentioning
confidence: 99%
“…For RCTs using soy protein as plant protein source, we included only RCTs intervening soy with zero or low isoflavone content and excluded those with moderate or high isoflavone content. For interventions using soy protein with different levels of isoflavones, only the group with the lowest isoflavone content was included to discount effects of isoflavones and focus on those of the protein ( 16 ). Outcomes included CVD (mortality and incidence), T2D, and related cardiometabolic risk factors.…”
Section: Methodsmentioning
confidence: 99%
“…Phytochemicals with present antioxidant properties are vitamins A, C, and E, selenium, zinc, carotenoids, flavonoids, and several other phenolic compounds [45]. Besides that, the use of isoflavones can be effective in correction and improving the lipid profile and metabolism in postmenopausal women and could favorably prevent cardiovascular events [46].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, soy isoflavones are often considered phytoestrogens 21 . A few recent meta-analyses of randomized controlled trials showed the favorable effects of soy isoflavones on METS components, such as blood pressure, lipids, and glycemic control 22-24 . Moreover, genistein intake can improve metabolic disorders, such as hyperglycemia and hyperlipidemia 25 .…”
Section: Discussionmentioning
confidence: 99%